What Can Diabetes-Associated Genetic Variation in TCF7L2 Teach Us About the Pathogenesis of Type 2 Diabetes?

被引:9
|
作者
Adams, J. D. [1 ]
Vella, Adrian [1 ]
机构
[1] Mayo Clin, Coll Med, Endocrine Res Unit, Dept Endocrinol Diabet & Nutr, 200 First St SW,Rm 5-194 Joseph, Rochester, MN 55905 USA
基金
美国国家卫生研究院;
关键词
common genetic variation; insulin secretion; insulin action; type; 2; diabetes; PATHWAY EFFECTOR TCF7L2; INSULIN-SECRETION; BETA-CATENIN; SUSCEPTIBILITY GENE; GLUCOSE-METABOLISM; PROGLUCAGON GENE; CELL FUNCTION; WNT; POLYMORPHISMS; EXPRESSION;
D O I
10.1089/met.2018.0024
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Type 2 diabetes mellitus (T2DM) is a polygenic metabolic disorder characterized by hyperglycemia occurring as a result of impaired insulin secretion and/or insulin resistance. Among the various genetic factors associated with T2DM, a common genetic variant within the transcription factor 7-like 2 locus (TCF7L2) confers the greatest genetic risk for development of the disease. However, the mechanism(s) by which TCF7L2 predisposes to diabetes remain uncertain. Here we review the current literature pertaining to the potential mechanisms by which TCF7L2 confers risk of T2DM, using genetic variation as a probe to understand the pathogenesis of the disease.
引用
收藏
页码:383 / 389
页数:7
相关论文
共 50 条
  • [1] No detectable effect of a type 2 diabetes-associated TCF7L2 genotype on the incretin effect
    Mathiesen, David S.
    Bagger, Jonatan, I
    Hansen, Katrine B.
    Junker, Anders E.
    Plamboeck, Astrid
    Harring, Signe
    Idorn, Thomas
    Hornum, Mads
    Holst, Jens J.
    Jonsson, Anna E.
    Hansen, Torben
    Vilsboll, Tina
    Lund, Asger
    Knop, Filip K.
    ENDOCRINE CONNECTIONS, 2020, 9 (12): : 1221 - 1232
  • [2] The TCF7L2 Gene Polymorphisms and the Relationship between TCF7L2 Gene and Type 2 Diabetes: A review
    Zhang Zhong
    Xie Yue
    Gao Zhi-Mou
    PROCEEDINGS OF 2009 INTERNATIONAL CONFERENCE OF NATURAL PRODUCT AND TRADITIONAL MEDICINE, VOLS 1 AND 2, 2009, : 377 - 383
  • [3] Molecular Function of TCF7L2: Consequences of TCF7L2 Splicing for Molecular Function and Risk for Type 2 Diabetes
    Hansson, Ola
    Zhou, Yuedan
    Renstrom, Erik
    Osmark, Peter
    CURRENT DIABETES REPORTS, 2010, 10 (06) : 444 - 451
  • [4] The Role of TCF7L2 in Type 2 Diabetes
    del Bosque-Plata, Laura
    Martinez-Martinez, Eduardo
    Angel Espinoza-Camacho, Miguel
    Gragnoli, Claudia
    DIABETES, 2021, 70 (06) : 1220 - 1228
  • [5] Diabetes-associated genetic variation in TCF7L2 alters pulsatile insulin secretion in humans
    Laurenti, Marcello C.
    Dalla Man, Chiara
    Varghese, Ron T.
    Andrews, James C.
    Rizza, Robert A.
    Matveyenko, Aleksey
    De Nicolao, Giuseppe
    Cobelli, Claudio
    Vella, Adrian
    JCI INSIGHT, 2020, 5 (07)
  • [6] Genetic variation in TCF7L2 rs7903146 and history of GDM negatively and independently impact on diabetes-associated metabolic traits
    Fritsche, Louise
    Sarief, Mirjam
    Wagner, Robert
    Stefan, Norbert
    Lehmann, Rainer
    Haering, Hans-Ulrich
    Grallert, Harald
    Fritsche, Andreas
    Lechner, Andreas
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2018, 146 : 251 - 257
  • [7] Genetic variants of TCF7L2 are associated with type 2 diabetes in a northeastern Chinese population
    Qiao, Hong
    Zhang, Xuelong
    Zhao, Xuedan
    Zhao, Yanling
    Xu, Lidan
    Sun, Haiming
    Fu, Songbin
    GENE, 2012, 495 (02) : 115 - 119
  • [8] An alternative effector gene at the type 2 diabetes-associated TCF7L2 locus?
    van de Bunt, Martijn
    DIABETOLOGIA, 2016, 59 (11) : 2292 - 2294
  • [9] Type 2 diabetes-associated genetic variants of FTO, LEPR, PPARg, and TCF7L2 in gestational diabetes in a Brazilian population
    Anghebem-Oliveira, Mauren Isfer
    Martins, Bruna Rodrigues
    Alberton, Dayane
    de Souza Ramos, Edneia Amancio
    Picheth, Geraldo
    de Moraes Rego, Fabiane Gomes
    ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2017, 61 (03): : 238 - 248
  • [10] The TCF7L2 Locus: A Genetic Window Into the Pathogenesis of Type 1 and Type 2 Diabetes
    Grant, Struan F. A.
    DIABETES CARE, 2019, 42 (09) : 1624 - 1629